Alpha1-adrenergic receptors: new insights and directions.

M T Piascik, Dianne M. Perez

PubMed · 2001 · 330 citations · 55 references

Concepts

TL;DR

Adrenergic receptors regulate sympathetic activity and are therapeutic targets, with alpha1 subtypes mediating smooth muscle contraction and hypertrophic growth but remaining less characterized than other family members, despite sharing ligand affinity but differing in binding mode, signaling, and physiological effects. This review surveys recent literature on the alpha1‑adrenergic receptor binding pocket, signaling pathways, and emerging roles in smooth muscle, growth, neurological, and cardiovascular function. The authors analyze recent studies describing the alpha1‑adrenergic receptor binding pocket, signaling components, and functional distinctions from beta‑adrenergic receptors.

Abstract

The adrenergic receptors play a key role in the modulation of sympathetic nervous system activity as well as a site of action for many therapeutic agents. The alpha1-adrenergic receptor subtypes (alpha1A-, alpha1B-, alpha1D) are the prime mediators of smooth muscle contraction and hypertrophic growth, but their characterization in both binding and function have lagged the other adrenergic family members. Although they are derived from a related ancestral gene and all nine adrenergic receptor family members bind the endogenous ligands, epinephrine and norepinephrine, with roughly similar affinities, there are major differences in the mode of binding, second messenger utilization, and physiological effects of the alpha1-subtypes compared with beta- or alpha2-subtypes. Here, we review the recent literature on aspects of its binding pocket and how it differs from the beta-adrenergic receptor paradigms. We also review the signaling components and aspects of its function and provide new insights into its roles in smooth muscle, growth, neurological, and cardiovascular function.

References

55